Medivation Reiterates Rejection Of Sanofi's Inadequate Proposal To Buy It

By: via Benzinga
Medivation, Inc. (NASDAQ: MDVN) reaffirmed its rejection of Sanofi's (NYSE: SNY) substantially inadequate proposal to buy the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.